DEA’s suspension of McKesson Corporation Retraction

Posted in Latest News on January 19, 2017.

The previous post, regarding the DEA’s suspension of McKesson Corporation’s sales of controlled substances from distribution in Florida, was found to be confusing. This suspension will impact one distribution center in Florida and impacts only the handling of hydromorphone. The Florida Department of Health and Division of Medical Quality Assurance apologizes for any confusion that may have resulted from that message. For specific details about McKesson’s agreement with the DEA, please contact the DEA. For questions about the potential impact of the sanctions in Florida, please contact the DOH’s Medical Quality Assurance.



More Latest News

Florida Nursing Quarterly – Vol. 10 Issue 1
March 4, 2024

The latest issue of the Florida Nursing Quarterly
is now available. Continue reading


Board of Nursing Meeting
February 2, 2024

The agenda for the upcoming March 4, 2024, Board Meeting has been published. You may locate the agenda by visiting https://floridasnursing.gov/meeting-information/upcoming-meetings/. Thank you, Florida Board of Nursing